European Network of Gynaecological Oncological Trial Groups
The European Network for Gynaecological Oncological Trial groups (ENGOT) is a research network of the European Society of Gynaecological Oncology (ESGO) and was founded in Berlin in October 2007.
Currently, ENGOT consists of 19 trial groups from 14 European countries.
Click here to see ENGOT groups
Click here to see ENGOT trials
ENGOT is a platform that guarantees that the European spirit and culture is incorporated into the medical progress in gynaecological oncology, and that all European patients and countries can participate in an active way in clinical research and progress.
The ultimate goal is to bring the best treatment to gynecological cancer patients through the best science, and enabling every patient in every European country to access a clinical trial.
As a network of national and regional clinical trial units, ENGOT coordinates and promotes clinical trials within Europe on patients with gynaecological cancer. This coordination is particularly relevant for academic clinical trials, translational research, research on rare diseases, and for clinical trials sponsored by the industry to perform multinational studies in Europe.
The ENGOT Assembly further set up new objectives and strategies: 1-Incorporate Translational Research into clinical trials and build up a Phase I-II trials network, 2- Harmonize operational aspects and improve quality of trials and 3-Provide teaching and mentoring.
ENGOT´s Requirements from trials Trials Between Academic Groups and Pharmaceutical Companies, (Int J of Gynecological Cancer: 2010, 20: pp 476-478)
Roadmap for the ENGOT trials, (Int J of Gynecological Cancer: 2013, 23: pp 1339-1343)
ENGOT guidelines for authorship
ENGOT recommended Good Clinical Practice (GCP) online training__________
For more information, do not hesitate to contact us.